Jul 13, 2023 2 min read Evelo Biosciences Inc: Raises New Capital A troubled publicly-traded biotech company has raised new capital at the last minute but neither the business nor its BDC lender are yet safe. This post is for paying subscribers only Subscribe now Already have an account? Sign in